Pricing Log in Create free account
Saturday 31 October 2026 Export ABBV’s income statement to Excel — free account

AbbVie Inc.

ABBV Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 290.4%, free cash flow fell 36.2% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

294.90 4.11 +1.41%
Market cap
$513.9B
P/E
83.3×
Fwd P/E
36.5×
Dividend yield
2.35%
F-score
8/9
Altman Z
2.31
Beneish M
−2.86
Dividend safety
44/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Filings

AbbVie Inc. (ABBV) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Oct 30, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 14, 2026 5.02 Departure or appointment of directors or officers Officer departure
8-K Oct 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 3, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 18, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Aug 4, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026 P1I2: 18 added · 2 removed · 32 modified
P2I1A: no comparison — the Item was not found
8-K Jul 31, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 18, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 8, 2026 5.07 Submission of matters to a vote of security holders
10-Q Mar 31, 2026
8-K Apr 29, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 3, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 4, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 24, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 4 added · 7 removed · 51 modified
1A: 11 added · 22 modified
7: 39 added · 41 removed · 35 modified
8-K Feb 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 7, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 31, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 3, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 11, 2025 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Jul 31, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 3, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K Apr 25, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 3, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Jan 31, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Oct 30, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 3, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Jul 25, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 3, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 26, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 3, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 2, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 5, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.